Cynosure Management, LLC Cytokinetics Inc Transaction History
Cynosure Management, LLC
- $854 Million
- Q2 2025
A detailed history of Cynosure Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Cynosure Management, LLC holds 10,372 shares of CYTK stock, worth $622,734. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,372
Previous 7,788
33.18%
Holding current value
$622,734
Previous $312,000
9.62%
% of portfolio
0.04%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding CYTK
# of Institutions
371Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.06 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$881 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$720 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$470 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$383 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.65B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...